SCHEMBL7093643

SCHEMBL7093643

CCOC(=O)COc1cccc(-c2n[nH]c3c2Cc2ccccc2-3)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.53
CHEK1 O14757 1/20 0.48
CDK1 P06493 1/20 0.47
CDK2 P24941 1/20 0.47
KIT P10721 2/20 0.47
FLT1 P17948 2/20 0.47
LCK P06239 1/20 0.47
CSF1R P07333 1/20 0.47
FLT3 P36888 1/20 0.47
PDGFRB P09619 1/20 0.43
HIF1A Q16665 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 2/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
GAA P10253 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7090397 0.92 KDR (0.50) KDRCHEK1CDK1CDK2KIT
SCHEMBL7000821 0.87 KDR (0.62) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL7088696 0.86 KDR (0.57) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL7002255 0.82 KDR (0.61) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL7090918 0.82 KDR (0.58) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL6995193 0.82 KDR (0.55) KDRCHEK1CDK1CDK2LCK
SCHEMBL7090440 0.80 KDR (0.46) KDRCHEK1CDK1CDK2KIT
SCHEMBL6967822 0.80 KDR (0.67) KDRCHEK1CDK1CDK2KIT
SCHEMBL7136211 0.79 KDR (0.54) KDRCHEK1CDK1CDK2FLT3
SCHEMBL7144911 0.79 KDR (0.56) KDRCHEK1CDK1CDK2PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed